Sponsor Pipeline

Yukinori Ozaki Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06976944 Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer Recurrent Triple-Negative Breast Cancer Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Yukinori Ozaki's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free